Defective Drug Recalls Lawyer Broward County, FL

Top 10 Most Commonly Recalled Drugs in the U.S. — What happened, why, and what patients should do

Drug recalls are common. The FDA maintains an active recalls page and searchable recall database because manufacturers or regulators may remove products for reasons ranging from microbial contamination to subpotency, impurities (including nitrosamines such as NDMA), mislabeling, and sterility failures. Over the last two decades some drugs or categories have appeared in repeated or high-impact recalls; those are listed here with plain-English explanations and action steps for patients. U.S. Food and Drug Administration+1

How this list was chosen: no single public list ranks “most recalled” by a simple count; instead this roundup targets drugs and drug families that have repeatedly shown up in FDA recall actions or have had major, widely reported recalls (large volume, public health impact or repeated manufacturer recalls). For each item I list the typical recall reason and what patients or caregivers should do.

1) ARBs — Valsartan, Losartan, Irbesartan (Angiotensin II Receptor Blockers)

Why they’re on this list: since 2018 multiple lots and manufacturers of ARBs (notably valsartan, and later losartan and irbesartan) were recalled worldwide after tests detected nitrosamine impurities (NDMA, NDEA) that are probable human carcinogens. Because these impurities were traced to certain active-ingredient manufacturing changes, numerous lots across many brands and generic makers were affected. U.S. Food and Drug AdministrationAHA Journals

Typical recall reason: nitrosamine contamination from the API (active pharmaceutical ingredient) manufacturing process.

What patients should do: don’t stop blood-pressure meds without talking to a clinician. Check FDA recall notices for specific lot/NDC numbers and follow pharmacy or manufacturer instructions. U.S. Food and Drug Administration

2) Ranitidine (brand: Zantac)

Why: the FDA requested removal of all ranitidine products in 2020 after testing showed variable — sometimes high — levels of NDMA in ranitidine products; NDMA could form during storage or over time, posing a potential cancer risk. This triggered recalls and market withdrawals for both OTC and prescription ranitidine. U.S. Food and Drug AdministrationWIRED

Typical recall reason: NDMA impurity / instability over time.

What patients should do: alternatives for heartburn/reflux (e.g., famotidine, PPIs) exist — discuss with your clinician or pharmacist. Do not abruptly stop medications unless advised. U.S. Food and Drug Administration

3) Metformin (extended-release formulations)

Why: several manufacturers voluntarily recalled certain extended-release (ER) metformin lots after FDA or company testing found NDMA above the acceptable daily intake. Because metformin is widely used for type 2 diabetes, these recalls received broad attention and repeated lot-by-lot actions. U.S. Food and Drug Administration+1

Typical recall reason: nitrosamine (NDMA) contamination in ER formulations.

What patients should do: continue therapy unless a clinician advises otherwise; immediate hyperglycemia risk from stopping metformin can be significant. Check lot numbers and talk to your pharmacist for replacements or alternates. ACOG

4) Heparin (2008 contamination and later actions)

Why: the 2007–2008 heparin crisis is one of the most severe drug-safety events in recent history: contaminated heparin API from overseas suppliers led to allergic-type reactions, many adverse events, and expanded recalls. The scale and severity (hospital IV use and deaths/injuries reported) put heparin high on the list of historically important recalls. PMCU.S. Food and Drug Administration

Typical recall reason: adulteration/contamination of the active ingredient (over-sulfated chondroitin sulfate) causing severe reactions.

What patients should do: heparin is typically administered in hospitals; providers were notified and supply chains were changed. If you or a family member had an unexplained severe reaction during a hospital infusion historically, request record review and notify clinicians. New England Journal of Medicine

5) Compounded sterile drugs (e.g., NECC methylprednisolone)

Why: compounding pharmacies have been the source of multiple high-impact recalls and safety alerts (notably the 2012 New England Compounding Center (NECC) fungal meningitis outbreak, when contaminated steroid injections caused hundreds of infections and many deaths). The NECC event led to voluntary recalls of all NECC products and major regulatory scrutiny. archive.cdc.govCDC

Typical recall reason: microbial contamination, sterility failures or mislabeling at compounding facilities.

What patients should do: if you received a compounded injection or sterile product from a facility later recalled, follow public health guidance (notifications often identify exposed lot numbers) and monitor for symptoms; clinicians should be informed. U.S. Food and Drug Administration

6) Thyroid medications (levothyroxine) — potency/subpotency recalls

Why: levothyroxine supplies are tightly regulated because small potency differences change thyroid control. Periodic recalls for subpotent lots or stability issues are common and can affect many patients (recent upgrades of levothyroxine recalls demonstrate ongoing manufacturing/potency issues). EmprU.S. Food and Drug Administration

Typical recall reason: assay below approved potency or stability/subpotency concerns.

What patients should do: don’t stop or change dose without discussing TSH monitoring with your clinician; pharmacies will usually notify affected patients. hmpgloballearningnetwork.com

7) Insulin delivery systems and insulin device software (pumps/apps)

Why: while insulin drugs are sometimes subject to recalls, device-related recalls (insulin pumps, pump apps) have been high profile because software or hardware faults that interrupt delivery can quickly become life-threatening for people with type 1 diabetes. Recent Class I recalls and safety notices affected large user pools. U.S. Food and Drug AdministrationVerywell Health

Typical recall reason: device malfunction, software bugs, or battery issues that risk interrupted insulin delivery.

What patients should do: follow manufacturer/FDA instructions immediately; keep backup insulin and supplies; update device firmware/apps as recommended. FDA Access Data

8) Antidepressants and other agents with nitrosamine findings (e.g., duloxetine)

Why: nitrosamine impurities are not limited to ARBs and metformin — in recent years nitroso-type impurities have been detected in other molecules (e.g., some lots of duloxetine/Cymbalta were reported recalled by some manufacturers), placing these drugs on watchlists for recalls. New York Post

Typical recall reason: nitrosamine impurities formed during synthesis.

What patients should do: do not stop prescribed antidepressants abruptly; consult your prescriber for safe alternatives or substitution guidance. New York Post

9) Various generic oral solids (tablets) with stability or impurity problems

Why: because generic production is large and globalized, recurring recalls often affect generic oral tablets across many therapeutic classes (antihypertensives, antibiotics, analgesics) when manufacturers detect impurities, dissolution failures, or labeling/packaging errors. Aggregated reports and FDA enforcement data show generics are commonly represented in recall lists. Lightfoot Law, PLLCU.S. Food and Drug Administration

Typical recall reason: impurities, subpotency, dissolution/specification failures, incorrect labeling.

What patients should do: check NDC and lot numbers; pharmacists often replace affected generics with unaffected lots or an alternative manufacturer. U.S. Food and Drug Administration

10) Over-the-counter (OTC) products and supplements sold as medicines

Why: although not always “prescription drugs,” OTC drug batches and some supplements marketed as drug substitutes are periodically recalled for contamination, mislabeling, or impurities. Recent high-profile OTC recalls (e.g., ranitidine) highlight that consumer products can appear on major recall lists. U.S. Food and Drug Administration

Typical recall reason: contaminants, undeclared ingredients, or impurities (e.g., NDMA).

What patients should do: read FDA recall notices and return products to the retailer or pharmacy as instructed; use regulated alternatives when possible. U.S. Food and Drug Administration

Quick information table

Frequently Asked Questions (FAQ)

Q: How does the FDA classify recalls?
A: Recalls are classified by risk: Class I (reasonable probability of serious adverse health consequences or death), Class II (temporary or reversible adverse health consequences), and Class III (use not likely to cause adverse health consequences). The FDA posts recall notices and searchable lists. U.S. Food and Drug Administration

Q: Should I stop taking a recalled drug immediately?
A: Usually no — do not stop a prescribed medication without talking to your healthcare provider. Many recalls are for impurities or lot-specific issues and clinicians will advise safe transitions or replacements. ACOG

Q: Where can I check whether my medicine was recalled?
A: The FDA maintains a public searchable Drug Recalls page and individual manufacturers post recall notices. Your pharmacy or prescriber can also check NDC (National Drug Code) and lot numbers. U.S. Food and Drug Administration

Q: How common are drug recalls?
A: Recalls happen regularly. Aggregated analyses show thousands of drug recall events over recent years; the majority are Class II and involve quality or specification issues rather than immediate life-threatening defects. Still, Class I recalls occur and are serious. Lightfoot Law, PLLCHarvard Health

Q: Can recalls be sued in court?
A: Potentially — patients harmed by defective or contaminated drugs may have legal claims (product liability, negligence). Legal recourse depends on the facts, proof of causation, and statute-of-limitations rules. Consult a lawyer for case-specific advice.

Final notes and sources

This article summarizes recurring or high-impact recalls seen in FDA reporting and major health coverage. Because recall patterns and active recall notices change frequently, always check the FDA Drug Recalls and individual manufacturer notices for the most current lot-specific information before taking action. Key sources used here include the FDA drug recalls pages, FDA press announcements (e.g., ranitidine removal), FDA company recall notices (metformin), historical reviews of the 2008 heparin crisis, and CDC/FDA reports on compounding pharmacy outbreaks.